- €7.17bn
- €13.49bn
- €673.80m
- 51
- 51
- 83
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 302 | 373 | 407 | 589 | 674 |
Cost of Revenue | |||||
Gross Profit | 246 | 303 | 334 | 465 | 554 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -316 | -18.9 | -969 | -458 | -650 |
Operating Profit | 618 | 392 | 1,377 | 1,048 | 1,324 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 501 | 290 | 1,277 | 951 | 1,212 |
Provision for Income Taxes | |||||
Net Income After Taxes | 392 | 253 | 1,026 | 764 | 923 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 392 | 252 | 1,026 | 767 | 923 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 392 | 252 | 1,026 | 767 | 923 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.16 | 0.77 | 2.68 | 1.77 | 2.07 |
Dividends per Share |